ROYCE & ASSOCIATES LP

Position in HROW — Harrow, Inc.

CIK 906304 New York, NY

Position in HROW

as of Mar 31, 2026 · filed May 12, 2026 Compact

Position Value

$1,400,280

-$23,577,274 QoQ

Shares Held

39,713

-92.2% QoQ

Ownership

0.107%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Jun 2023

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

ROYCE & ASSOCIATES LP holds $70,326,489 across 14 Drug Manufacturers - Specialty & Generic names. HROW ranks #12 (2.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	SUPN	Supernus Pharmaceuticals, Inc.	229,939	$11,885,546
2	ELAN	Elanco Animal Health Inc	469,916	$11,245,089
3	PBH	Prestige Consumer Healthcare Inc.	157,126	$9,312,858
4	COLL	Collegium Pharmaceutical, Inc	272,786	$9,021,033
5	AMPH	Amphastar Pharmaceuticals, Inc.	406,175	$7,956,968
6	ESPR	Esperion Therapeutics, Inc.	2,626,995	$7,197,966
7	SIGA	Siga Technologies Inc	667,646	$3,571,906
8	TKNO	Alpha Teknova, Inc.	1,069,162	$3,089,878

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,400,280	39,713	-92.2%	Shares	Sole	2026-05-12
2025-12-31	$24,977,554	509,746	-4.4%	Shares	Sole	2026-02-09
2025-09-30	$25,680,566	533,013	-3.7%	Shares	Sole	2025-11-12
2025-06-30	$16,909,784	553,693	+69.3%	Shares	Sole	2025-08-11
2025-03-31	$8,700,753	327,096	+12.0%	Shares	Sole	2025-05-06
2024-12-31	$9,799,619	292,090	-18.9%	Shares	Sole	2025-02-10
2024-09-30	$16,199,987	360,320	-33.3%	Shares	Sole	2024-11-06
2024-06-30	$11,278,511	539,900	+71.5%	Shares	Sole	2024-08-13
2024-03-31	$4,166,127	314,900	+6.8%	Shares	Sole	2024-05-13
2023-12-31	$3,302,880	294,900	+1.7%	Shares	Sole	2024-02-12
2023-09-30	$4,167,300	290,000	+58.5%	Shares	Sole	2023-11-09
2023-06-30	$3,484,320	183,000	—	Shares	Sole	2023-08-07
No filing history on record for this holder in this stock.